These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29599339)

  • 21. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
    Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
    Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
    Franko J; Voynov G; Goldman CD
    Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.
    Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M
    Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant variation of resected meso-esophageal tissue volume in two-stage subtotal esophagectomy specimens: a retrospective morphometric study.
    Izon AS; Jose P; Hayden JD; Grabsch HI
    Ann Surg Oncol; 2013 Mar; 20(3):788-97. PubMed ID: 22983387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma.
    Badreddine RJ; Prasad GA; Lewis JT; Lutzke LS; Borkenhagen LS; Dunagan KT; Wang KK
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):248-53. PubMed ID: 19948247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depth of Invasion into the Circular and Longitudinal Muscle Layers in T2 Esophageal Squamous Cell Carcinoma Does Not Affect Prognosis or Lymph Node Metastasis: A Multicenter Retrospective Study.
    Tian D; Huang H; Yang YS; Jiang KY; He X; Guo XG; Chen LQ
    World J Surg; 2020 Jan; 44(1):171-178. PubMed ID: 31552458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma.
    Kaneshiro DK; Post JC; Rybicki L; Rice TW; Goldblum JR
    Am J Surg Pathol; 2011 May; 35(5):697-700. PubMed ID: 21490446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of lymph node status in superficial esophageal carcinoma.
    Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
    Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
    Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
    Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
    Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer.
    Muijs C; Smit J; Karrenbeld A; Beukema J; Mul V; van Dam G; Hospers G; Kluin P; Langendijk J; Plukker J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):845-52. PubMed ID: 24411191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer.
    Philippron A; Bollschweiler E; Kunikata A; Plum P; Schmidt C; Favi F; Drebber U; Hölscher AH
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):549-558. PubMed ID: 28043475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Perioperative Chemotherapy in Lymph Node-negative Esophageal Cancer After Resection: A Population-based Study With Propensity Score-matched Analysis.
    Yang Y; Zhou X; Tang L; Xu X; Du X; Qiu G
    Am J Clin Oncol; 2019 Dec; 42(12):924-931. PubMed ID: 31651453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
    Wang J; Suri JS; Allen PK; Liao Z; Komaki R; Ho L; Hofstetter WL; Lin SH
    Am J Clin Oncol; 2016 Jun; 39(3):228-35. PubMed ID: 24710122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esophageal submucosa: the watershed for esophageal cancer.
    Raja S; Rice TW; Goldblum JR; Rybicki LA; Murthy SC; Mason DP; Blackstone EH
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1403-11.e1. PubMed ID: 22093714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.